CoChat
Sign Up
Cited by 207

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease: A Randomized Clinical Trial

Kieburtz, Karl, Tilley, Barbara C., Elm, Jordan J., Babcock, Debra, Hauser, Robert, Ross, G. Webster, Augustine, Alicia H., Augustine, Erika U., Aminoff, Michael J., Bodis-Wollner, Ivan G., Boyd, James, Cambi, Franca, Chou, Kelvin, Christine, Chadwick W., Cines, Michelle, Dahodwala, Nabila, Derwent, Lorelei, Dewey, Richard B., Hawthorne, Katherine, Houghton, David J., Kamp, Cornelia, Leehey, Maureen, Lew, Mark F., Liang, Grace S. Lin, Luo, Sheng T., Mari, Zoltan, Morgan, John C., Parashos, Sotirios, Pérez, Adriana, Petrovitch, Helen, Rajan, Suja, Reichwein, Sue, Roth, Jessie Tatsuno, Schneider, Jay S., Shannon, Kathleen M., Simon, David K., Simuni, Tanya, Singer, Carlos, Sudarsky, Lewis, Tanner, Caroline M., Umeh, Chizoba C., Williams, Karen, Wills, Anne-Marie·2015·JAMA
DOI 10.1001/jama.2015.120PMC PMC4349346
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2015.120

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 25

  1. [1]Dorsey ER Constantinescu R Thompson JP Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology 2007 68 5 384 386 17082464
  2. [2]Kowal SL Dall TM Chakrabarti R Storm MV Jain A The current and projected economic burden of Parkinson’s disease in the United States Mov Disord 2013 28 3 311 318 23436720
  3. [3]Ravina BM Fagan SC Hart RG Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment Neurology 2003 60 8 1234 1240 12707423
  4. [4]NINDS NET-PD Investigators A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease Neurology 2006 66 5 664 671 16481597
  5. [5]NINDS NET-PD Investigators A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology 2007 68 1 20 28 17200487
  6. [6]NINDS NET-PD Investigators A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results Clin Neuropharmacol 2008 31 3 141 150 18520981 PMC4372145
  7. [7]Tilley BC Palesch YY Kieburtz K NET-PD Investigators Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs Neurology 2006 66 5 628 633 16534099
  8. [8]Elm JJ NINDS NET-PD Investigators Design innovations and baseline findings in a long-term Parkinson’s trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson’s Disease Long-Term Study-1 Mov Disord 2012 27 12 1513 1521 23079770 PMC3481179
  9. [9]Huang P Goetz CG Woolson RF Parkinson Study Group Using global statistical tests in long-term Parkinson’s disease clinical trials Mov Disord 2009 24 12 1732 1739 19514076 PMC2813508
  10. [10]Schwab R England A Gillingham F Donaldson I Projection technique for evaluating surgery in Parkinson’s disease Third Symposium on Parkinson’s Disease Edinburgh, Scotland E & S Livingstone 1969 152 157
  11. [11]Bushnell DM Martin ML Quality of life and Parkinson’s disease: translation and validation of the US Parkinson’s Disease Questionnaire (PDQ-39) Qual Life Res 1999 8 4 345 350 10472167
  12. [12]Jenkinson C Fitzpatrick R Norquist J Findley L Hughes K Cross-cultural evaluation of the Parkinson’s Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain J Clin Epidemiol 2003 56 9 843 847 14505768
  13. [16]Marinus J Visser M Verwey NA Assessment of cognition in Parkinson’s disease Neurology 2003 61 9 1222 1228 14610124
  14. [20]Tomlinson CL Stowe R Patel S Rick C Gray R Clarke CE Systematic review of levodopa dose equivalency reporting in Parkinson’s disease Mov Disord 2010 25 15 2649 2653 21069833
  15. [21]Huang P Tilley BC Woolson RF Lipsitz S Adjusting O’Brien’s test to control type I error for the generalized nonparametric Behrens-Fisher problem Biometrics 2005 61 2 532 539 16011701 PMC2827210
  16. [22]Lan KK Wittes J The B-value: a tool for monitoring data Biometrics 1988 44 2 579 585 3390511
  17. [23]Ellenberg SS Fleming TR DeMets DL Data Monitoring Committees in Clinical Trials: A Practical Perspective London, United Kingdom John Wiley & Sons 2002
  18. [24]Luo S Lawson AB He B Elm JJ Tilley BC Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson’s disease clinical trial published online December 18, 2012 Stat Methods Med Res 10.1177/0962280212469358 PMC3883900 23242384 · DOI
  19. [25]Whitehead J The Design and Analysis of Sequential Clinical Trials Rev 2nd ed Chichester, United Kingdom John Wiley & Sons 1997
  20. [26]Krige D Carroll MT Cooper JM Marsden CD Schapira AH Royal Kings and Queens Parkinson Disease Research Group Platelet mitochondrial function in Parkinson’s disease Ann Neurol 1992 32 6 782 788 1471869
  21. [27]Parker WD Jr Boyson SJ Parks JK Abnormalities of the electron transport chain in idiopathic Parkinson’s disease Ann Neurol 1989 26 6 719 723 2557792
  22. [28]Schapira AH Cooper JM Dexter D Clark JB Jenner P Marsden CD Mitochondrial complex I deficiency in Parkinson’s disease J Neurochem 1990 54 3 823 827 2154550
  23. [29]Klivenyi P Gardian G Calingasan NY Yang L Beal MF Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease J Mol Neurosci 2003 21 3 191 198 14645986
  24. [30]Matthews RT Ferrante RJ Klivenyi P Creatine and cyclocreatine attenuate MPTP neurotoxicity Exp Neurol 1999 157 1 142 149 10222117
  25. [31]Gray R Ives N Rick C PD Med Collaborative Group Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial Lancet 2014 384 9949 1196 1205 24928805

Cited by

Sorted by citations

Metadata

Authors
Kieburtz, K., Tilley, B. C., Elm, J. J., Babcock, D., Hauser, R., Ross, G. W., Augustine, A. H., Augustine, E. U., Aminoff, M. J., Bodis-Wollner, I. G., Boyd, J., Cambi, F., Chou, K., Christine, C. W., Cines, M., Dahodwala, N., Derwent, L., Dewey, R. B., Hawthorne, K., Houghton, D. J., Kamp, C., Leehey, M., Lew, M. F., Liang, G. S. L., Luo, S. T., Mari, Z., Morgan, J. C., Parashos, S., Pérez, A., Petrovitch, H., Rajan, S., Reichwein, S., Roth, J. T., Schneider, J. S., Shannon, K. M., Simon, D. K., Simuni, T., Singer, C., Sudarsky, L., Tanner, C. M., Umeh, C. C., Williams, K., & Wills, A.-M.
Affiliations
  • University of Rochester, Rochester, New York
  • University of Texas Health Science Center at Houston
  • Medical University of South Carolina, Charleston
  • National Institutes of Health, Bethesda, Maryland
  • University of South Florida, Tampa
  • Pacific Health Research and Education Institute, Honolulu, Hawaii
  • University of California, San Francisco
  • State University of New York Downstate Medical Center, Brooklyn
  • University of Vermont, Burlington
  • University of Kentucky, Lexington
  • University of Michigan, Ann Arbor
  • University of Maryland School of Medicine, Baltimore
  • University of Pennsylvania, Philadelphia
  • University of Calgary, Calgary, Alberta, Canada
  • University of Texas Southwestern Medical Center, Dallas
  • University of Southern California, Los Angeles
  • Ochsner Medical Center, New Orleans, Louisiana
  • University of Colorado Denver, Aurora
  • The Parkinson’s Institute and Clinical Center, Sunnyvale, California
  • Johns Hopkins University, Baltimore, Maryland
  • Georgia Regents University, Augusta
  • Struthers Parkinson’s Center, Golden Valley, Minnesota
  • Thomas Jefferson University, Philadelphia, Pennsylvania
  • Rush University Medical Center, Chicago, Illinois
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts
  • Northwestern University, Chicago, Illinois
  • University of Miami, Miami, Florida
  • Brigham and Women’s Hospital, Boston, Massachusetts
Venue
JAMA
Publisher
American Medical Association (AMA)
Published
2015-02-10
Volume
313
Issue
6
Pages
584
ISSN
0098-7484
DOI
10.1001/jama.2015.120
PMC
PMC4349346
Cited by
207
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review